###begin article-title 0
AP-2alpha Induces Epigenetic Silencing of Tumor Suppressive Genes and Microsatellite Instability in Head and Neck Squamous Cell Carcinoma
###end article-title 0
###begin p 1
Conceived and designed the experiments: KB CE. Performed the experiments: KB. Analyzed the data: KB. Contributed reagents/materials/analysis tools: TR. Wrote the paper: KB. Helped offer critique of experiments: TR. Suggested some experiments and also offered sufficient feedback on the written portion: CE.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 440 450 416 422 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C/EBP&#945;</italic>
###xml 518 528 490 496 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C/EBP&#945;</italic>
###xml 317 324 <span type="species:ncbi:9606">patient</span>
Activator protein 2 alpha (AP-2alpha) is involved in a variety of physiological processes. Increased AP-2alpha expression correlates with progression in various squamous cell carcinomas, and a recent publication found AP-2alpha to be overexpressed in approximately70% of Head and Neck Squamous Cell Carcinoma (HNSCC) patient samples. It was found to repress transcription of the tumor suppressor gene C/CAAT Enhancer Binding Protein alpha (C/EBPalpha), and its binding site correlated with upstream methylation of the C/EBPalpha promoter. Therefore, we investigated the potential for AP-2alpha to target methylation to additional genes that would be relevant to HNSCC pathogenesis.
###end p 3
###begin title 4
Principal Findings
###end title 4
###begin p 5
###xml 178 182 174 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MLH1</italic>
Stable downregulation of AP-2alpha stable by shRNA in HNSCC cell lines correlated with decreased methylation of its target genes' regulatory regions. Furthermore, methylation of MLH1 in HNSCC with and without AP-2alpha downregulation revealed a correlation with microsatellite instability (MSI). ChIP analysis was used to confirm binding of AP-2alpha and HDAC1/2 to the targets. The effects of HDAC inhibition was assessed using Trichostatin A in a HNSCC cell line, which revealed that AP-2alpha targets methylation through HDAC recruitment.
###end p 5
###begin title 6
Conclusions
###end title 6
###begin p 7
These findings are significant because they suggest AP-2alpha plays a role not only in epigenetic silencing, but also in genomic instability. This intensifies the potential level of regulation AP-2alpha has through transcriptional regulation. Furthermore, these findings have the potential to revolutionize the field of HNSCC therapy, and more generally the field of epigenetic therapy, by targeting a single gene that is involved in the malignant transformation via disrupting DNA repair and cell cycle control.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 228 231 207 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006931-Damberg1">[1]</xref>
###xml 333 336 308 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006931-Jiang1">[2]</xref>
###xml 359 362 334 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006931-Damberg1">[1]</xref>
###xml 401 404 376 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006931-Han1">[3]</xref>
###xml 521 524 492 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006931-Imagawa1">[4]</xref>
###xml 615 618 582 585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006931-Bosher1">[5]</xref>
###xml 620 623 587 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006931-HilgerEversheim1">[6]</xref>
###xml 787 790 754 757 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006931-Oyama1">[7]</xref>
###xml 892 895 855 858 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006931-Han1">[3]</xref>
###xml 897 900 860 863 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006931-Gille1">[8]</xref>
###xml 962 965 921 924 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21</italic>
###xml 970 974 929 933 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDH1</italic>
###xml 1033 1036 992 995 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006931-Orso1">[9]</xref>
###xml 1148 1151 1103 1106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006931-Han1">[3]</xref>
###xml 1153 1156 1108 1111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006931-Bosher1">[5]</xref>
###xml 1158 1161 1113 1116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006931-Gille1">[8]</xref>
###xml 1283 1286 1238 1241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006931-Orso1">[9]</xref>
The Activator Protein-2 family is composed of five members (alpha, beta, gamma, epsilon, delta). These genes are transcription factors that play roles in apoptosis, cell cycle regulation, tissue differentiation, and development [1]. Activator protein 2 alpha (AP-2alpha) is involved in a variety of processes, including adipogenesis [2], neuronal development [1], and is suspect in cancer progression [3]. AP-2alpha binds as a homo or heterodimer to targets that contain the motif "GCCNNNGGC" in their regulatory regions [4]. After binding, AP-2alpha can either function as a transcriptional activator or repressor [5], [6]. It is normally expressed at very low levels in keratinocytes, and it is elevated in proliferating, malignant keratinocytes of squamous cell carcinoma of the skin [7]. Furthermore, UVA irradiation increases AP-2alpha expression and results in malignant transformation [3], [8]. Because AP-2alpha transcriptionally regulates such genes as p21 and CDH1, it is feasible to propose its relevance in tumorigenesis [9]. In fact, AP-2alpha has been shown to act as both a tumor suppressor and an oncogene in different cancer types [3], [5], [8]. It appears this is determined by the type and quantity of AP-2 isoforms and AP-2 modulating factors present in the cell [9].
###end p 9
###begin p 10
###xml 166 170 166 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006931-Jones1">[10]</xref>
###xml 172 176 172 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006931-Fujita1">[11]</xref>
###xml 279 283 279 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006931-Singh1">[12]</xref>
###xml 633 637 633 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006931-Uramoto1">[13]</xref>
Histone and promoter DNA methylation have been revealed in the past decade to be a frequent cause of gene silencing of tumor suppressors in a variety of malignancies [10], [11]. DNA methylation sterically inhibits transcription factor binding, thereby inhibiting gene activation [12]. Conversely, decreased gene transcription has been shown in some cases to precede and propogate DNA methylation, resulting in more stable gene downregulation. For example, a transcriptional suppressor protein that competes with a transcriptional activator for the same binding site could result in decreased activation through increased methylation [13].
###end p 10
###begin p 11
###xml 120 124 116 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006931-Bennett1">[14]</xref>
###xml 126 130 122 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006931-Liu1">[15]</xref>
###xml 239 242 235 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006931-Jiang1">[2]</xref>
###xml 244 248 240 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006931-Zhang1">[16]</xref>
###xml 364 368 356 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006931-Liu1">[15]</xref>
###xml 507 511 495 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006931-Taylor1">[17]</xref>
AP-2alpha is one such example, providing transcriptional repression to some genes which are also epigenetically modified[14], [15]. It competes with the activator SP1 for binding to these target promoters, thereby repressing transcription [2], [16]. AP-2alpha has previously been shown to recruit HDACs to specific gene promoters following retinoic acid induction [15], and a recent study observed that regions of frequent methylation in Acute Lymphoblastic Leukemia often contained AP-2alpha binding sites [17]. Therefore, it is reasonable to hypothesize that in cancer cells AP-2alpha may bind to specific target genes, silence transcription, and propagate DNA methylation in order to stably silence tumor suppressors and DNA repair genes.
###end p 11
###begin p 12
The following study investigates 8 target genes in HNSCC for the possibility of AP-2alpha-induced targeted methylation and subsequent gene silencing. Decreased AP-2alpha expression was found to correlate with decreased target methylation, increased target gene expression, and decreased microsatellite instability. ChIP analysis revealed an association between AP-2alpha and HDAC binding to target promoters. Also, the effect of HDAC inhibition on target methylation mirrored that of AP-2alpha downregulation. Therefore, the mechanism of AP-2alpha-induced methylation is likely explained by HDAC recruitment.
###end p 12
###begin title 13
Results
###end title 13
###begin title 14
AP-2alpha downregulation decreases target gene methylation
###end title 14
###begin p 15
###xml 97 101 93 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006931-Bennett1">[14]</xref>
###xml 102 111 98 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006931-g001">Figure 1a</xref>
###xml 208 216 200 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006931.s001">Table S1</xref>
###xml 568 573 552 557 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RARB2</italic>
###xml 575 578 559 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DCC</italic>
###xml 580 584 564 568 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DAPK</italic>
###xml 586 590 570 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTEN</italic>
###xml 592 602 576 586 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MLH1, CDH1</italic>
###xml 604 607 588 591 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P73</italic>
###xml 613 620 597 604 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RASSF1A</italic>
###xml 622 631 606 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006931-g001">Figure 1b</xref>
###xml 636 645 620 629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006931.s003">Figure S2</xref>
###xml 808 817 788 797 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006931.s002">Figure S1</xref>
###xml 854 865 834 845 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RARB2, PTEN</italic>
###xml 867 871 847 851 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MLH1</italic>
###xml 873 877 853 857 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDH1</italic>
###xml 883 890 863 870 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RASSF1A</italic>
###xml 1009 1018 985 994 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006931-g001">Figure 1b</xref>
###xml 1048 1057 1024 1033 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006931-g001">Figure 1d</xref>
Using a previously generated HNSCC cell line (SCC22B) in which AP-2alpha is stably downregulated [14](Figure 1a), DNA methylation was analyzed in 16 potential AP-2alpha target genes' promoters (list shown in Table S1). These genes were selected based on previous evidence for methylation in a variety of malignancies and potential regulation by AP-2alpha (i.e. the presence of consensus AP-2alpha binding sites in the target's promoter). A preliminary methylation screen was performed in wildtype SCC22B cells, which yielded methylation in 8/16 of the targets tested: RARB2, DCC, DAPK, PTEN, MLH1, CDH1, P73, and RASSF1A (Figure 1b and Figure S2). Bisulfite sequencing was then performed on these eight genes in SCC22B cells with and without AP-2alpha downregulation (detailed gene diagrams are displayed in Figure S1). Of these eight genes, five genes (RARB2, PTEN, MLH1, CDH1, and RASSF1A) showed some level of demethylation in the SCC22B cells with AP-2alpha downregulation compared to the wildtype cells (Figure 1b; graphical representation in Figure 1d).
###end p 15
###begin title 16
Targeted methylation and repression via AP-2alpha in HNSCC cell lines SCC22B.
###end title 16
###begin p 17
a) Western blot analysis to confirm AP-2alpha downregulation in SCC22B. b) Via bisulfite sequencing analysis, methylation of 5 target genes was compared between SCC22B cells with and without AP-2alpha expression. Gene drawings indicate the CpG island and bisulfite PCR product in relationship to the transcription start site (arrow). Solid circles represent methylated CpGs; whereas, open circles represent unmethylated CpG sites. The small bars represent the location of the predicted AP-2alpha site. c) Western blot analysis was performed to analyze methylation's effect on target expression. d) Graphical representation of the average methylation percentage in the 5 target genes analyzed. * P-value = 0.042; ** P-value = 0.040; *** P-value = 0.014.
###end p 17
###begin title 18
Decreased target gene methylation correlates with decreased expression
###end title 18
###begin p 19
###xml 251 255 247 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTEN</italic>
###xml 257 261 253 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MLH1</italic>
###xml 267 274 263 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RASSF1A</italic>
###xml 304 311 300 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RASGRF2</italic>
###xml 313 322 309 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006931-g001">Figure 1c</xref>
###xml 343 347 339 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDH1</italic>
###xml 542 551 530 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006931-g001">Figure 1c</xref>
###xml 552 556 540 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006931-Suyama1">[18]</xref>
###xml 606 610 590 594 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTEN</italic>
###xml 610 614 594 598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006931-Choi1">[19]</xref>
###xml 660 664 640 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MLH1</italic>
###xml 669 676 649 656 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RASSF1A</italic>
In order to assess the significance of the target methylation, western blot analysis was performed on lysates from the wildtype and AP-2alpha-downregulated SCC22B cells. This revealed a visible increase in protein expression in 3/5 of the genes (i.e. PTEN, MLH1, and RASSF1A) and no detectable change in RASGRF2 (Figure 1c). Not surprisingly, CDH1 showed a decrease in protein expression in response to AP-2alpha-downregulation, which correlates with previous findings that AP-2alpha is required for activation, not repression, of this gene (Figure 1c)[18]. AP-2alpha has previously been shown to regulate PTEN[19], but the findings of AP-2alpha regulation of MLH1 and RASSF1A are novel.
###end p 19
###begin p 20
###xml 85 94 81 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006931-g002">Figure 2a</xref>
###xml 233 240 225 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RASSF1A</italic>
###xml 242 246 234 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MLH1</italic>
###xml 252 256 244 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTEN</italic>
###xml 310 314 302 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTEN</italic>
###xml 319 323 311 315 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MLH1</italic>
###xml 374 390 362 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006931-g002">Figure 2b and 2d</xref>
###xml 495 504 479 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006931-g002">Figure 2c</xref>
###xml 652 656 632 636 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MLH1</italic>
###xml 669 673 649 653 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006931-Esteller1">[20]</xref>
###xml 675 679 655 659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006931-Leung1">[21]</xref>
###xml 681 685 661 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006931-Thibodeau1">[22]</xref>
###xml 764 774 740 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006931.s004">Figure S3a</xref>
###xml 904 914 880 890 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006931.s004">Figure S3b</xref>
###xml 931 935 907 911 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTEN</italic>
###xml 940 947 916 923 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RASSF1A</italic>
###xml 1091 1101 1063 1073 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006931.s004">Figure S3c</xref>
AP-2alpha was also downregulated in additional HNSCC cell lines (SCC11B and SCC17as)(Figure 2a). The methylation status of the 3 genes with decreased methylation and increased expression in AP-2alpha-downregulated SCC22B cells (i.e. RASSF1A, MLH1, and PTEN) was analyzed. SCC17as displayed subtle decreases in PTEN and MLH1 methylation in the AP-2alpha-downregulated cells (Figure 2b and 2d), and both SCC11B and SCC17as revealed increased target gene expression after AP-2alpha downregulation (Figure 2c). AP-2alpha-targeted methylation was also investigated in malignancies other than HNSCC, and colon cancer was selected based on the association of MLH1 methylation [20], [21], [22]. AP-2alpha was downregulated in two colon cancer cell lines, HCT116 and HT29 (Figure S3a). The region analyzed for MLH1 showed insignificant methylation levels in the vector-only cancer cells for both HT29 and HCT116 (Figure S3b). However, both PTEN and RASSF1A demonstrated slightly higher levels of methylation, which were decreased in correlation with AP-2alpha downregulation in both HT29 and HCT116 (Figure S3c).
###end p 20
###begin title 21
Varied target methylation and expression following AP-2alpha downregulation in HNSCC cell lines SCC11B and SCC17as.
###end title 21
###begin p 22
a) Western blot analysis to confirm AP-2alpha downregulation in SCC11B and SCC17as. b) Methylation in 3 target genes was compared between SCC11B and SCC17as cells with and without AP-2alpha expression. Solid circles represent methylated CpGs; whereas, open circles represent unmethylated CpG sites. c) Western blot analysis was performed to analyze methylation's affect on target expression. d) Graphical representation of the average methylation percentage in the 3 target genes analyzed.
###end p 22
###begin title 23
AP-2alpha downregulation seems to be associated with decreased MSI
###end title 23
###begin p 24
###xml 15 19 15 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MLH1</italic>
###xml 154 158 154 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006931-Esteller1">[20]</xref>
###xml 160 164 160 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006931-Leung1">[21]</xref>
###xml 166 170 166 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006931-Thibodeau1">[22]</xref>
###xml 432 441 424 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006931-g003">Figure 3a</xref>
###xml 689 698 677 686 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006931-g003">Figure 3a</xref>
Methylation of MLH1, a DNA repair gene, has been previously shown to correlate with microsatellite instability in colon, gastric, and endometiral cancers [20], [21], [22]. Therefore, MSI was compared in SCC22B, SCC17as, SCC11B, HCT116, and HT29 cells with and without AP-2alpha downregulation. Interestingly, MSI primers yielded fewer products in both SCC22B and SCC17as AP-2alpha-downregulated cells compared to the control cells (Figure 3a) (SCC22B = Bat25, D18S487, D17S250, D2S123, Bat40, and D18S56; SCC17as = Bat25, D18S487, D2S123, D18S67, and Bat40; D18S56 did not amplify in SCC17as). This suggests a potential decrease in MSI in these cells correlating with decreased AP-2alpha (Figure 3a). As expected, the cell lines that exhibited no change in MLH1 methylation (SCC11B, HT29, and HCT116) in the region tested did not reflect any changes in MSI with AP-2alpha downregulation (data not shown).
###end p 24
###begin title 25
Decreased MSI following AP-2alpha downregulation in HNSCC cell lines SCC22B and SCC17as.
###end title 25
###begin p 26
a) 9 MSI markers were used with DNA from SCC22B and SCC17as cells with and without AP-2alpha downregulation, and the products were analyzed on an 8% PAGE gel. b) ChIP analysis using an AP-2alpha antibody in SCC22B cells with and without AP-2alpha downregulation. ChIP eluate was then utilized for quantitative PCR using MLH1 promoter primers. c) Bisulfite sequencing analysis of 3 additional DNA repair genes in WT SCC22B cells. Because no methylation was observed in the WT cells, it was unnecessary to analyze methylation in AP-2alpha downregulated cells. Solid circles represent methylated CpGs; whereas, open circles represent unmethylated CpG sites.
###end p 26
###begin p 27
###xml 52 56 48 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MLH1</italic>
###xml 189 193 177 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MLH1</italic>
###xml 272 281 256 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006931-g003">Figure 3b</xref>
###xml 358 368 342 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MSH3, PMS2</italic>
###xml 374 379 358 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAD50</italic>
###xml 569 578 549 558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006931-g003">Figure 3c</xref>
In order to confirm AP-2alpha actually binds to the MLH1 promoter, ChIP analysis was performed in SCC22B with and without AP-2alpha downregulation. This revealed AP-2alpha does bind to the MLH1 promoter, and this binding is decreased in the AP-2alpha-downregulated cells (Figure 3b). Methylation screening was performed for additional DNA repair genes (i.e. MSH3, PMS2, and RAD50) that contained both CpG islands and potential AP-2alpha binding sites within their promoter elements. This bisulfite sequencing analysis revealed relatively no methylation of these genes (Figure 3c).
###end p 27
###begin title 28
Decreased AP-2alpha and HDAC1/2 binding to target promoters following AP-2alpha downregulation
###end title 28
###begin p 29
###xml 155 159 151 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006931-Liu1">[15]</xref>
###xml 500 504 484 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTEN</italic>
###xml 536 545 520 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006931-g004">Figure 4a</xref>
###xml 751 758 727 734 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RASSF1A</italic>
###xml 1022 1026 990 994 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDH1</italic>
In a previous publication, AP-2alpha binding to target promoters was shown to precede recruitment of HDAC proteins to the region for more stable silencing [15]. Therefore, to address the mechanism by which AP-2alpha may affect gene methylation and silencing in these HNSCC cells, ChIP analysis was performed on SCC22B cells with and without downregulation of AP-2alpha. As expected, this semi-quantitative analysis revealed AP-2alpha and HDAC1/2 binding to all of the target promoters tested, except PTEN, in the wildtype SCC22B cells (Figure 4a). Furthermore, both AP-2alpha and HDAC binding was reduced in the AP-2alpha downregulated cells. HDAC1 was found to be more frequently associated with the targets compared to HDAC2, which did not pulldown RASSF1A. Since AP-2alpha and SP1 bind to the same consensus sequence, SP1 binding was also investigated in order to assess whether increased target gene expression was due to the restored binding of the activator SP1 following removal of AP-2alpha. With the exception of CDH1, decreased AP-2alpha binding did not allow increased SP1 binding as would have been expected.
###end p 29
###begin title 30
AP-2alpha interacts with HDAC1/2, and HDAC activity is required for targeted methylation in HNSCC cells.
###end title 30
###begin p 31
###xml 197 201 189 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDH1</italic>
###xml 203 210 195 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RASGRF2</italic>
###xml 212 216 204 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MLH1</italic>
###xml 218 225 210 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RASSF1A</italic>
###xml 231 235 223 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTEN</italic>
###xml 687 689 679 681 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;6</sup>
a) ChIP analysis was performed using AP-2alpha, SP1, HDAC1, and HDAC2 antibodies in SCC22B cells with and without AP-2alpha downregulation. ChIP eluate was then utilized for quantitative PCR using CDH1, RASGRF2, MLH1, RASSF1A, and PTEN promoter primers. b) Western blot analysis demonstrating increased acetylation following Trichostatin A (TSA) treatment. c) Bisulfite sequencing analysis was performed in SCC22B cells before and after TSA treatment. Solid circles represent methylated CpGs; whereas, open circles represent unmethylated CpG sites. d) Graphical representation of the average methylation percentage in the 3 target genes analyzed. * P-value = 0.0452; ** P-value = 3.77x10-6.
###end p 31
###begin title 32
HDAC inhibition's effect on target methylation correlates with AP-2alpha downregulation
###end title 32
###begin p 33
###xml 267 276 263 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006931-g004">Figure 4b</xref>
###xml 403 407 399 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTEN</italic>
###xml 412 416 408 412 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MLH1</italic>
###xml 506 513 502 509 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RASSF1A</italic>
###xml 534 543 530 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006931-g004">Figure 4c</xref>
###xml 565 567 561 563 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;6</sup>
###xml 628 637 624 633 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006931-g004">Figure 4d</xref>
###xml 754 761 750 757 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RASSF1A</italic>
###xml 761 765 757 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006931-Kawamoto1">[23]</xref>
###xml 1029 1033 1025 1029 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006931-McCool1">[24]</xref>
In order to investigate whether the mechanism of AP-2alpha-targeted methylation involved HDAC recruitment and activity, class I and II HDACs were inhibited via Trichostatin A (TSA). Efficacy of TSA treatment was verified via western analysis for acetyl histone H4K5 (Figure 4b). Following TSA treatment, target methylation was then compared with that of the SCC22B cells with intact HDAC activity. Both PTEN and MLH1 demonstrated a significant decrease in methylation subsequent to TSA treatment; however, RASSF1A remained unchanged (Figure 4c; ** P-value = 3.77x10-6 and * 0.0452, respectively; graphical quantitation shown in Figure 4d). This correlates with previous findings that TSA alone is insufficient to change the histone acetylation status of RASSF1A[23]. However, no obvious change in target gene expression resulted from the increased acetylation (data not shown). This may be due to the brief time course (24 hours), which may not allow enough time for the methylation changes to reflect their impact on expression [24].
###end p 33
###begin title 34
AP-2alpha downregulation correlates with decreased mitosis
###end title 34
###begin p 35
###xml 370 379 354 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006931-g005">Figure 5a</xref>
###xml 610 619 578 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006931-g005">Figure 5b</xref>
Because AP-2alpha appears to target methylation and silencing of certain tumor suppressor genes in this HNSCC cell line, downregulation of AP-2alpha (i.e. relief of tumor suppressor silencing) should correlate with decreased proliferation. We performed cell cycle analysis by flow cytometry on the HNSCC cells SCC22B with endogenous AP-2alpha, AP-2alpha overexpression (Figure 5a), and downregulation of AP-2alpha. The pattern in AP-2alpha overexpressing cells looked similar to endogenous AP-2alpha expression; however, HNSCC cells with AP-2alpha downregulation exhibited significantly less cells in mitosis (Figure 5b; P-value = 0.0003).
###end p 35
###begin title 36
Decreased AP-2alpha expression reduces proliferation; and AP-2alpha is required for target remethylation following demethylation.
###end title 36
###begin p 37
a) AP-2alpha western blot analysis of SCC22B cells with AP-2alpha overexpression. b) Cell cycle analysis via flow cytometry comparing WT, AP-2alpha-overexpressing, and AP-2alpha-downregulated SCC22B cells. * P-value = 0.0003. c) Methylation sensitive HhaI digests were performed on DNAs from SCC22B cells with and without AP-2alpha downregulation, revealing no distinguishable difference in global DNA methylation. "M" = methylated; "U" = unmethylated. d) 1 microM 5-aza-2'deoxycytidine was applied to the cells for 96 hours, changing the media daily. After 96 hours, the 5-aza-2'deoxycytidine was removed and the cells were continued in culture for 10 days, collecting cells at 0, 7, and 10 days post-treatment. Combined bisulfite restriction analysis on bisulfite-treated DNA obtained from these cells at 0, 7, and 10 days. Increased methylation at 10 days is seen in the AP-2alpha-expressing cells (i.e. the digested band indicated by the arrow).
###end p 37
###begin title 38
###xml 44 48 40 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTEN</italic>
Lack of AP-2alpha inhibits remethylation of PTEN following 5-aza-2' deoxycytidine treatment
###end title 38
###begin p 39
###xml 310 319 302 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006931-g005">Figure 5c</xref>
###xml 743 747 723 727 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTEN</italic>
###xml 780 789 760 769 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006931-g005">Figure 5d</xref>
###xml 815 819 795 799 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTEN</italic>
###xml 902 906 878 882 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTEN</italic>
###xml 972 981 944 953 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006931-g005">Figure 5d</xref>
In order to exclude the possibility that AP-2alpha is affecting DNA methylation at the global level, an methylation sensitive digest was performed on DNAs from SCC22B cells with and without AP-2alpha downregulation. This revealed no substantial difference in DNA methylation levels between the two cell types (Figure 5c), suggesting the DNA methylation changes from AP-2alpha are gene-specific. To determine whether AP-2alpha acts to maintain or induce this specific target DNA methylation, the HNSCC cells SCC22B (+/- AP-2alpha shRNA) were treated with a demethylating drug (5-aza-2'deoxycytidine) and then permitted to recover methylation by continued culturing in the absence of the drug. Cells collected at 7 days post-treatment showed no PTEN methylation in both cell types (Figure 5d). However, after 10 days PTEN methylation was returning in the SCC22B cells with AP-2alpha expression, whereas, PTEN remained unmethylated in the cells lacking AP-2alpha expression (Figure 5d). Therefore, this is suggestive of a mechanism by which AP-2alpha induces target methylation.
###end p 39
###begin title 40
Discussion
###end title 40
###begin p 41
###xml 220 223 216 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006931-Oyama1">[7]</xref>
###xml 435 439 427 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006931-Provenzano1">[25]</xref>
###xml 479 486 467 474 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMAD2/3</italic>
###xml 555 559 540 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006931-Koinuma1">[26]</xref>
It has previously been shown that AP-2alpha is expressed at relatively low levels in normal keratinocytes and is significantly elevated in cancerous and proliferating keratinocytes in squamous cell carcinoma of the skin [7]. Forced expression of AP-2alpha in keratinocytes causes increased expression of the oncogene Amyloid Precursor Protein (APP), and these two genes have both been found to be increased in squamous cell carcinomas [25]. Furthermore, AP-2alpha interacts with SMAD2/3 to affect TGFBeta signaling, which is frequently disrupted in HNSCC [26]. These findings reveal the potential importance of AP-2alpha's transcriptional regulation of target genes in the pathogenesis of HNSCC.
###end p 41
###begin p 42
###xml 124 128 120 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006931-Yu1">[27]</xref>
###xml 271 274 263 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006931-Jiang1">[2]</xref>
###xml 276 280 268 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006931-Schulte1">[28]</xref>
###xml 661 666 645 650 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAD51</italic>
###xml 679 683 663 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006931-Hannay1">[29]</xref>
###xml 814 818 794 798 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MLH1</italic>
It has been suggested that AP-2alpha's ability to repress target genes results in cellular transformation and tumorigenesis [27], and decreased transcriptional suppression of AP-2alpha targets via abolished target binding has been shown to favor cellular differentiation [2], [28]. In agreement, the results of this study in HNSCC reveal that downregulating AP-2alpha increases target gene expression by decreasing promoter DNA methylation and results in decreased cellular proliferation. In addition to its effects on proliferation, AP-2alpha also has been shown to potentially impact microsatellite instability through its interaction with p53 and subsequent RAD51 suppression [29]. In this study, we demonstrate that AP-2alpha expression correlates with increased MSI in HNSCC cell lines, which correlates with MLH1 methylation and decreased expression.
###end p 42
###begin p 43
###xml 104 108 100 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006931-Liu1">[15]</xref>
It has been demonstrated that AP-2alpha may help to recruit HDACs to the promoters to which it is bound [15]. Therefore, we investigated the association between AP-2alpha and HDAC binding to target promoters. This revealed a correlation between AP-2alpha and HDAC binding, and HDAC inhibition via TSA yielded similar effects on target demethylation as AP-2alpha downregulation. In fact, in some cases such as SCC11B and SCC17as, deacetylation via HDAC recruitment may be the primary means of target silencing by AP-2alpha (since AP-2alpha downregulation yielded no accountable methylation changes). Therefore, this study reveals that AP-2alpha acts as a suppressor for certain "tumor suppressive" genes in HNSCC by targeting promoter methylation and/or deacetylation via HDAC recruitment.
###end p 43
###begin p 44
###xml 603 607 587 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006931-Bennett1">[14]</xref>
###xml 846 850 822 826 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTEN</italic>
###xml 855 862 831 838 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RASSF1A</italic>
###xml 918 922 894 898 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MLH1</italic>
###xml 594 602 <span type="species:ncbi:9606">patients</span>
Perhaps most interesting is the novel discovery that AP-2alpha is not only involved in the epigenetic silencing of tumor suppressor and DNA repair genes, but also appears to contribute to microsatellite instability in HNSCC. In this manner, AP-2alpha allows for both increased tumor proliferation and increased genomic instability. Furthermore, this phenomenon in HNSCC is distinct from the colon cancer cell lines used in this study, in which MSI appears to be unaffected by AP-2alpha expression changes. In light of a recent publication demonstrating AP-2alpha overexpression in 69% of HNSCC patients [14], these findings emphasize the impact AP-2alpha has in HNSCC pathogenesis. Therefore, clinical treatment that targets AP-2alpha expression in the context of the MSI-positive HNSCC tumor would potentially deter tumor proliferation (ie. via PTEN and RASSF1A reexpression) and resolve genomic instability (ie. via MLH1 reexpression).
###end p 44
###begin title 45
Methods
###end title 45
###begin title 46
Cell lines, antibodies, and plasmids
###end title 46
###begin p 47
###xml 707 711 695 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006931-Bennett1">[14]</xref>
###xml 16 21 <span type="species:ncbi:9606">human</span>
###xml 240 246 <span type="species:ncbi:9913">Bovine</span>
The established human HNSCC cell lines used in the study (SCC22B, SCC11B, and SCC17as) were kindly provided by Dr. Thomas Carey, University of Michigan. Cell lines were maintained in Dulbecco's Modified Eagle's Medium (DMEM) with 10% Fetal Bovine Serum (FBS) and 1% streptomycin/penicillin (S/P) antibiotics. MLH1 (abcam; ab9144), CDH1 (Cell Signaling; 4065), RASGRF1/2 (Santa Cruz; sc-28580), RASSF1A (abcam;ab23950), alpha-TUBULIN (Cell Signaling Technologies; Danvers, MA), PTEN (monoclonal antibody clone 6H2.1; Cascade Biosciences, Portland, OR), AP-2alpha (abcam; ab18112), and acetyl Histone H4 Lys 5 (Upstate Cell Signaling Solutions; 07-327). The AP-2alpha shRNA construct was previously described [14]. The AP-2alpha overexpression construct was made by PCR amplification of the complete AP-2alpha cDNA sequence, using primers with EcoRV and SalI ends. Blunt-end ligation was performed using pBABE following BamHI digestion and Klenow polymerase reaction.
###end p 47
###begin title 48
DNA isolation
###end title 48
###begin p 49
DNA was isolated using the DNA QiaAmp kit (Qiagen) according to the manufacturer's protocol.
###end p 49
###begin title 50
Trichostatin A (TSA) treatment
###end title 50
###begin p 51
The SCC22B cell line was treated with either 300 nM or 5 microM TSA for 24 hours. The cells were then collected for western blot analysis and DNA isolation. The 5 microM treated cells were used for the bisulfite sequencing analysis.
###end p 51
###begin title 52
5-aza-2'deoxycytidine treatment
###end title 52
###begin p 53
Cells were treated with 1 microM of the drug (Sigma-Aldrich) for 96 hours while maintaining approximately50% confluency and changing the drug daily.
###end p 53
###begin title 54
Western blot analysis
###end title 54
###begin p 55
Whole cell lysates were suspended in lamaelli buffer and boiled for 15 minutes, followed by centrifugation. Lysates were loaded onto a 7.5% acrylamide gel and run for 2 hours at 110 volts followed by semidry transfer of the proteins to nitrocellulose membranes. The membranes were then blocked in 5% milk for 1 hour. 1:1,000 dilution of the primary antibodies were incubated with the blot overnight shaking at 4 degrees Celsius. A one hour incubation with the secondary antibodies (1:5,000 dilution) followed. The blots were then washed in 1x TBS-Tween for 1 hour and films exposed using ECL solutions. Western blots are representative of three independent experiments.
###end p 55
###begin title 56
MSI analysis
###end title 56
###begin p 57
###xml 132 136 132 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006931-Boland1">[30]</xref>
###xml 138 142 138 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006931-Ogino1">[31]</xref>
###xml 144 148 144 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006931-Demokan1">[32]</xref>
###xml 150 154 150 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006931-Dietmaier1">[33]</xref>
Commonly used MSI primers were utilized for the analysis (Bat25, Bat26, Bat40, D2S123, D17S250, D18S55, D18S56, D18S67, and D18S487)[30], [31], [32], [33]. DNA was isolated from HNSCC SCC22B cells with and without AP-2alpha downregulation using the Qiagen DNA mini kit according to the standard protocol (Qiagen). 5 ng of this DNA (1 microl) was used for PCR along with 10 microl HotStart mix (Qiagen), 6 microl water, and 2 microl primer (20 pmol). The PCR products were subsequently subjected to electrophoresis on an 8% polyacrylamide gel.
###end p 57
###begin title 58
Combined Bisulfite Restriction Analysis (COBRA)
###end title 58
###begin p 59
###xml 44 48 44 48 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006931-Bennett2">[34]</xref>
COBRA was performed as previously described [34]. Primer sequences will be provided upon request.
###end p 59
###begin title 60
Bisulfite sequencing analysis
###end title 60
###begin p 61
###xml 59 63 59 63 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006931-Tada1">[35]</xref>
Bisulfite sequencing was performed as previously described [35]. Primer sequences will be provided upon request.
###end p 61
###begin title 62
Chromatin immunoprecipitation analysis
###end title 62
###begin p 63
###xml 47 51 47 51 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006931-Bennett2">[34]</xref>
ChIP analysis was done as previously described [34], according to the Upstate Cell Signaling Solutions protocol. Sequences of the primers used for the quantitative ChIP PCRs can be provided upon request.
###end p 63
###begin title 64
Hha I digest
###end title 64
###begin p 65
Global methylation status was analyzed in SCC22B cells +/- AP-2alpha shRNA. 1ug of DNA was incubated with 1 unit HhaI (New England Biolabs) at 37 degrees Celsius for 3 hours. The digests were then loaded onto a 1% agarose gel for comparison.
###end p 65
###begin title 66
Supporting Information
###end title 66
###begin p 67
(0.08 MB RTF)
###end p 67
###begin p 68
Click here for additional data file.
###end p 68
###begin p 69
Diagram of 5 genes displaying the amplified region in respect to the corresponding gene and associated CpG island. Bisulfite sequencing analysis was performed on five genes which yielded differences in methylation following AP-2alpha downregulation in HNSCC. The diagram shows the location of the bisulfite PCR product, the CpG island, and the gene layout. The numbers provided are in respect to the transcription start site.
###end p 69
###begin p 70
(2.55 MB DOC)
###end p 70
###begin p 71
Click here for additional data file.
###end p 71
###begin p 72
Some methylated genes in HNSCC are unaffected by AP-2alpha downregulation. Bisulfite sequencing analysis was performed on three genes which yielded no substantial differences in methylation following AP-2alpha downregulation. Solid circles represent methylated CpGs; whereas, open circles represent unmethylated CpG sites.
###end p 72
###begin p 73
(2.07 MB TIF)
###end p 73
###begin p 74
Click here for additional data file.
###end p 74
###begin p 75
AP-2alpha downregulation in colon cancer cell lines causes a subtle decrease in RASSF1A and PTEN methylation. a) Western blot analysis showing AP-2alpha downregulation in HT29 and HCT116 cell lines. b) Bisulfite sequencing analysis on MLH1 shows little methylation in WT HCT116 and HT29 cell lines. c) Bilsulfite sequencing analysis on RASSF1A and PTEN in HCT116 and HT29 colon cancer cell lines with and without AP-2alpha downregulation. Solid circles represent methylated CpGs; whereas, open circles represent unmethylated CpG sites.
###end p 75
###begin p 76
(1.67 MB TIF)
###end p 76
###begin p 77
Click here for additional data file.
###end p 77
###begin p 78
We thank Dr. Thomas Carey for the provision of the HNSCC cell lines used in this study, and members of the Eng lab, and Drs. Aaron Gruver, Angela Ting, and Micheala Aldred for thoughtful discussions. CE is the Sondra J. and Stephen R. Hardis Chair of Cancer Genomic Medicine at the Cleveland Clinic, a Doris Duke Distinguished Clinical Scientist, and an American Cancer Society Clinical Research Professor.
###end p 78
###begin title 79
References
###end title 79
###begin article-title 80
Transcription factor AP-2 and monoaminergic functions in the central nervous system.
###end article-title 80
###begin article-title 81
Sequential repression and activation of the CCAAT enhancer-binding protein-alpha (C/EBPalpha) gene during adipogenesis.
###end article-title 81
###begin article-title 82
Induction of ErbB2 by ultraviolet A irradiation: potential role in malignant transformation of keratinocytes.
###end article-title 82
###begin article-title 83
Transcription factor AP-2 mediates induction by two different signal-transduction pathways: protein kinase C and cAMP.
###end article-title 83
###begin article-title 84
A family of AP-2 proteins regulates c-erbB-2 expression in mammary carcinoma.
###end article-title 84
###begin article-title 85
Regulatory roles of AP-2 transcription factors in vertebrate development, apoptosis and cell-cycle control.
###end article-title 85
###begin article-title 86
###xml 114 119 <span type="species:ncbi:9606">human</span>
Different properties of three isoforms (alpha, beta, and gamma) of transcription factor AP-2 in the expression of human keratinocyte genes.
###end article-title 86
###begin article-title 87
Ultraviolet-A-induced transactivation of the vascular endothelial growth factor gene in HaCaT keratinocytes is conveyed by activator protein-2 transcription factor.
###end article-title 87
###begin article-title 88
AP-2alpha and AP-2gamma regulate tumor progression via specific genetic programs.
###end article-title 88
###begin article-title 89
Relationships between chromatin organization and DNA methylation in determining gene expression.
###end article-title 89
###begin article-title 90
Methylation-mediated transcriptional silencing in euchromatin by methyl-CpG binding protein MBD1 isoforms.
###end article-title 90
###begin article-title 91
Chromatin and cancer: causes and consequences.
###end article-title 91
###begin article-title 92
p73 competes with co-activators and recruits histone deacetylase to NF-Y in the repression of PDGF beta-receptor.
###end article-title 92
###begin article-title 93
Activator protein 2 alpha (AP2alpha) suppresses 42 kDa C/CAAT enhancer binding protein alpha (p42(C/EBPalpha)) in head and neck squamous cell carcinoma.
###end article-title 93
###begin article-title 94
Nucleophosmin acts as a novel AP2alpha-binding transcriptional corepressor during cell differentiation.
###end article-title 94
###begin article-title 95
Requirement for proximal putative Sp1 and AP-2 cis-deoxyribonucleic acid elements in mediating basal and luteinizing hormone- and insulin-dependent in vitro transcriptional activation of the CYP17 gene in porcine theca cells.
###end article-title 95
###begin article-title 96
Large-scale CpG methylation analysis identifies novel candidate genes and reveals methylation hotspots in acute lymphoblastic leukemia.
###end article-title 96
###begin article-title 97
###xml 85 90 <span type="species:ncbi:9606">human</span>
Identification of AP-2-regulated genes by macroarray profiling of gene expression in human A375P melanoma.
###end article-title 97
###begin article-title 98
The AP-2alpha transcription factor is required for the ganglioside GM3-stimulated transcriptional regulation of a PTEN gene.
###end article-title 98
###begin article-title 99
MLH1 promoter hypermethylation is associated with the microsatellite instability phenotype in sporadic endometrial carcinomas.
###end article-title 99
###begin article-title 100
hMLH1 promoter methylation and lack of hMLH1 expression in sporadic gastric carcinomas with high-frequency microsatellite instability.
###end article-title 100
###begin article-title 101
Microsatellite instability in colorectal cancer: different mutator phenotypes and the principal involvement of hMLH1.
###end article-title 101
###begin article-title 102
Epigenetic modifications of RASSF1A gene through chromatin remodeling in prostate cancer.
###end article-title 102
###begin article-title 103
The role of histone acetylation in regulating early gene expression patterns during early embryonic stem cell differentiation.
###end article-title 103
###begin article-title 104
AP-2 participates in the transcriptional control of the amyloid precursor protein (APP) gene in oral squamous cell carcinoma.
###end article-title 104
###begin article-title 105
Chromatin immunoprecipitation on microarray analysis of Smad2/3 binding sites reveals roles of ETS1 and TFAP2A in transforming growth factor beta signaling.
###end article-title 105
###begin article-title 106
Tumorigenic effect of transcription factor hAP-2alpha and the intricate link between hAP-2alpha activation and squelching.
###end article-title 106
###begin article-title 107
Transcription factor AP2alpha (TFAP2a) regulates differentiation and proliferation of neuroblastoma cells.
###end article-title 107
###begin article-title 108
###xml 55 60 <span type="species:ncbi:9606">human</span>
Rad51 overexpression contributes to chemoresistance in human soft tissue sarcoma cells: a role for p53/activator protein 2 transcriptional regulation.
###end article-title 108
###begin article-title 109
A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.
###end article-title 109
###begin article-title 110
Distinct molecular features of colorectal carcinoma with signet ring cell component and colorectal carcinoma with mucinous component.
###end article-title 110
###begin article-title 111
Microsatellite instability and methylation of the DNA mismatch repair genes in head and neck cancer.
###end article-title 111
###begin article-title 112
Diagnostic microsatellite instability: definition and correlation with mismatch repair protein expression.
###end article-title 112
###begin article-title 113
Tumor suppressor activity of CCAAT/enhancer binding protein alpha is epigenetically down-regulated in head and neck squamous cell carcinoma.
###end article-title 113
###begin article-title 114
Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.
###end article-title 114
###begin p 115
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 115
###begin p 116
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported in part by the Doris Duke Distinguished Clinical Scientist Award and Cleveland Clinic Strategic Investment Funds to the Genomic Medicine Institute (both to CE)[Grant number 20020346]. CE is the Sondra J. and Stephen R. Hardis Chair of the Cancer Genomic Medicine at the Cleveland Clinic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 116

